Consent to the Distribution of Changed Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Moclobemide 150 mg, 300 mg Tablets F Hoffmann-La Roche Limited, Basle, Switzerland Aurorix Venlafaxine hydrochloride 84.85 mg, 169.7 mg equivalent to 75 mg, 150 mg venlafaxine Capsule, modified release Ayerst-Wyeth Pharmaceuticals Inc., Guayama, Puerto Rico Efexor-XR Granisetron hydrochloride equivalent to 1 mg/mL granisetron in 1 mL, 3 mL Solution, infusion, ampoule SmithKline Beecham Pharmaceuticals, Magpie Wood, Manor Royal, Crawley, Sussex, England and Wulfing Pharma GmbH., Gronau/Leine, Germany Kytril Sodium chloride 0.85% w/v in 60 mL, 120 mL, 240 mL, 360 mL Solution, contact lens Allergan Pharmaceuticals (Ireland) Limited, Westport, County Mayo, Eire Lens Plus Purite Leuprorelin acetate 3.75 mg, 11.25 mg Diluent: carmellose sodium 5 mg/mL, mannitol 50 mg/mL, polysorbate 80 (tween 80) 1 mg/mL in 2 mL Injection, powder for, vial; Injection, ampoule Takeda Chemical Industries Limited, Shonan, Fugisawa-shi, Japan Lucrin Depot Tropisetron hydrochloride 1.128 mg/mL equivalent to 1 mg/mL tropisetron in 2 mL, 5 mL Injection, ampoule Novartis Pharma AG, Basle, Switzerland Navoban Tropisetron hydrochloride 5.64 mg equivalent to 5 mg tropisetron Capsule Novartis Pharma AG, Basle, Switzerland Navoban Nicotine 2 mg Tablet, sublingual Ferring AB., Malmo, Sweden Nicorette Microtabs Epirubicin hydrochloride 10 mg, 50 mg Injection, powder for, vial Pharmacia, Milan, Italy Pharmorubicin Epirubicin hydrochloride 2 mg/mL in 5 mL, 25 mL, 100 mL Injection, vial Pharmacia & Upjohn SpA., Milan, Italy Pharmorubicin Dated this 17th day of March 1998. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.